Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.47%
1,067.36
+4.96
+0.47%
—1,062.401,064.141,071.991,061.02——
SIXC
Communications
SIXC
Communications
SIXC
-0.54%
603.48
-3.26
-0.54%
—606.74606.74609.84602.33——
SIXE
Energy
SIXE
Energy
SIXE
+0.54%
1,244.93
+6.72
+0.54%
—1,238.211,236.601,247.741,232.10——
SIXI
Industrials
SIXI
Industrials
SIXI
+0.68%
1,730.38
+11.77
+0.68%
—1,718.611,723.231,741.481,717.47——
SIXM
Financials
SIXM
Financials
SIXM
+0.33%
639.47
+2.10
+0.33%
—637.37638.27642.30638.27——
SIXR
Staples
SIXR
Staples
SIXR
+0.16%
854.95
+1.36
+0.16%
—853.59854.05858.19851.34——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.11%
218.56
+0.23
+0.11%
—218.33218.33219.73217.15——
SIXT
Technology
SIXT
Technology
SIXT
+1.02%
3,631.59
+36.78
+1.02%
—3,594.813,620.103,657.473,615.34——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.80%
915.77
+7.23
+0.80%
—908.54909.50917.35907.07——
SIXV
Health care
SIXV
Health care
SIXV
+1.19%
1,512.81
+17.81
+1.19%
—1,495.001,499.611,517.101,499.61——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.41%
2,408.21
+9.90
+0.41%
—2,398.312,406.822,421.802,404.22——
KROS:NASDAQ
Keros Therapeutics Inc
$11.19
-0.27%
(-0.030) 1D
$11.19
0.00% (0.00)
After hours
Closed: May 22, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KROS...
Open
$11.22
High
$11.41
Low
$11.07
Mkt. cap
221.47M
Avg. vol.
338.20K
Volume
271.06K
52-wk high
$22.55
52-wk low
$9.79
EPS
-$3.01
Beta
0.95
Shares outstanding
19.79M
No. of employees
87
News stories
From sources across the web
About Keros Therapeutics Inc
CEO-
Employees87
Founded2015
HeadquartersLexington, Massachusetts, United States
SectorBiotechnology
Websitekerostx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
18.17M
14.26M
385.00K
367.00K
Cost of goods sold
43.50M
19.52M
17.81M
16.10M
Cost of revenue
43.50M
19.52M
17.81M
16.10M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
14.48M
10.13M
11.74M
10.15M
Operating expense
14.48M
10.13M
11.74M
10.15M
Total operating expenses
57.98M
29.65M
29.56M
26.24M
Operating income
-39.82M
-15.38M
-29.17M
-25.88M
Other non operating income
-
-
-539.00K
-
EBT including unusual items
-32.92M
-8.70M
-24.98M
-23.71M
EBT excluding unusual items
-32.92M
-8.70M
-24.88M
-23.71M
Income tax expense
-2.22M
-1.42M
-1.51M
-
Effective tax rate
6.75%
16.36%
6.06%
-
Other operating expenses
-
-
-
-
Net income
-30.70M
-7.28M
-23.46M
-23.71M
Net profit margin
-168.96%
-51.04%
-6,093.77%
-6,459.95%
Earnings per share
-0.76
-0.18
-0.86
-1.21
Interest and investment income
7.12M
6.93M
4.02M
2.34M
Interest expense
-
-
-
-
Net interest expenses
7.12M
6.93M
4.02M
2.34M
Depreciation and amortization charges
-
-
-
-
EBITDA
-39.45M
-14.99M
-28.77M
-25.47M
Gain or loss from assets sale
-14.00K
-
1.00K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer